Combination Therapy of Killing Diseases by Injectable Hydrogels: From Concept to Medical Applications

Abstract

The complexity of hard-to-treat diseases strongly undermines the therapeutic potential of available treatment options. Therefore, a paradigm shift from monotherapy toward combination therapy has been observed in clinical research to improve the efficiency of available treatment options. The advantages of combination therapy include the possibility of synchronous alteration of different biological pathways, reducing the required effective therapeutic dose, reducing drug resistance, and lowering the overall costs of treatment. The tunable physical properties, excellent biocompatibility, facile preparation, and ease of administration with minimal invasiveness of injectable hydrogels (IHs) have made them excellent candidates to solve the clinical and pharmacological limitations of present systems for multitherapy by direct delivery of therapeutic payloads and improving therapeutic responses through the formation of depots containing drugs, genes, cells, or a combination of them in the body after a single injection. In this review, currently available methods for the design and fabrication of IHs are systematically discussed in the first section. Next, as a step toward establishing IHs for future multimodal synergistic therapies, recent advances in cancer combination therapy, wound healing, and tissue engineering are addressed in detail in the following sections. Finally, opportunities and challenges associated with IHs for multitherapy are listed and further discussed.

Angelica gigas root ameliorates ischaemic stroke-induced brain injury in mice by activating the PI3K/AKT/mTOR and MAPK pathways

“… 2017 ; Poustchi et al. 2021 ). When ischaemic stroke occurs, cerebral inflammation and cell death are induced in the affected region, and deterioration of mitochondrial functions is activated by harmful stimuli such as brain arterial ischaemia and reperfusion (Sims and Muyderman 2010 ).…”

Berberine Attenuates Cerebral Ischemia-Reperfusion Injury Induced Neuronal Apoptosis by Down-Regulating the CNPY2 Signaling Pathway

“…It is mainly caused by the blockage of cerebral blood vessels, which leads to the dysfunction of regional cerebral blood supply. Its disability rate, recurrence rate and mortality rate are high, seriously endangering human physical and mental health ( Poustchi et al, 2021 ). The progression of clinical and basic research has led to improvements in the treatment of stroke, in particular mechanical thrombectomy and thrombolysis.…”

Triblock Copolymer Nanomicelles Loaded with Curcumin Attenuates Inflammation via Inhibiting the NF-κB Pathway in the Rat Model of Cerebral Ischemia

“…Stroke is currently the second leading cause of death and long-term disability in developed countries and its trend is on the rise. 1,2 About 85% of strokes are caused by ischemia, which results from thrombosis, embolism, and decreased systemic blood flow. 3 Delayed improvement in blood flow due to the activation of the oxidative stress process causes greater damage than the initial damage, which leads to endothelial dysfunction, capillary obstruction, damage to tissue and oxygen supply, followed by blood-brain barrier disruption, and cerebral edema.…”